← European Medicine Shortage Tracker · all medicines

Brimonidin tartrat shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Brimonidin tartrat currently has availability issues reported in 1 European register: Austria.

Shortage  ATC S01EA05 · also listed as: BRIMONIDIN TARTRAT · data refreshed 5 November 2026

Key facts

As of 5 November 2026, 1 of the 10 tracked registers list current availability issues for Brimonidin tartrat, covering 2 affected product presentations. The longest-running open report was filed in Austria on 2026-02-13 and has now been open for about 9 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-11-15; the earliest is 2026-11-05. In the WHO ATC classification, Brimonidin tartrat is coded S01EA05 — a medicine acting on sensory organs — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaShortage
Alpha-Vision sine 2 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis (PZN 4953122)
+ 1 more products
BRIMOGEN 2 mg/ml Augentropfen, Lösung (PZN 3925307)
2026-02-132026-11-15Erhöhter Mehrbedarfregister ↗

New register reports per month

2026-02: 12026-03: 02026-04: 02026-05: 02026-06: 02026-07: 02026-08: 12026-022026-08

Full report history (2 register entries)

Every individual register entry for Brimonidin tartrat in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇦🇹 ATAlpha-Vision sine 2 mg/ml Augentropfen, Lösung im EinzeldosisbehältnisShortage2026-08-122026-11-15Erhöhter Mehrbedarf
🇦🇹 ATBRIMOGEN 2 mg/ml Augentropfen, Lösung (PZN 3925307)Shortage2026-02-132026-11-05Produktionstransfer zu einem alternativen Hersteller

Frequently asked

Is Brimonidin tartrat currently in shortage in Europe?

Yes. As of 5 November 2026, availability issues are reported in: Austria. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Brimonidin tartrat shortage expected to end?

Agency prognoses on file range from 2026-11-05 to 2026-11-15. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Where does this Brimonidin tartrat availability data come from?

Directly from the official medicines-agency register that lists Brimonidin tartrat: BASG (Austria). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Brimonidin tartrat — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/brimonidin-tartrat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Brimonidin tartrat availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/brimonidin-tartrat/">Brimonidin tartrat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Brimonidin tartrat: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 5 November 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.